Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in DSGN — Design Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$244,599
+$94,215 QoQ
Shares Held
16,904
+19.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 25% Shared 0% None 75%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. DSGN ranks #224 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in DSGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $244,599 16,904
2026-03-31 $150,384 14,134
2025-12-31 $135,549 14,451
2025-09-30 $174,852 23,221
2025-06-30 $61,753 18,325
2025-03-31 $74,408 19,277
2024-12-31 $550,455 89,215
2024-09-30 $218,895 40,687
2024-06-30 $47,516 14,184
2024-03-31 $155,976 38,704
2023-12-31 $109,337 41,260
2023-09-30 $132,965 56,342
2023-06-30 $327,491 51,983
2023-03-31 $149,766 25,956
2022-12-31 $203,147 19,800
2022-09-30 $1,557,499 93,152
2022-06-30 $256,046 18,289
2022-03-31 $326,858 20,239
2021-12-31 $336,885 15,735
2021-09-30 $119,531 8,137
2021-06-30 $159,019 7,995